Intellectual Property Reform concerning bio-pharmaceutical industry Proposed policies regarding corporate tax reform - regarding all bio-pharmaceutical related provisions Issues related to the 340B Drug Pricing Program - regarding all bio-pharmaceutical related provisions Inflation Reduction Act implementation H.R. 1319, American Rescue Plan Act of 2021 - regarding all bio-pharmaceutical related provisions S 464/H.R. 2163, Safe Step Act - regarding all bio-pharmaceutical related provisions Discussions regarding health equity PBM reform including S.4293, Pharmacy Benefit Manager Transparency Act of 2022 H.R.485, Protecting Health Care for All Patients of 2023 Act H.R.830, HELP Copays Act of 2023 Discussions in support of H.R.5376, Share the Savings with Seniors Act Discussions in support of H.R.5539, ORPHAN Cures Act H.R.3561, The PATIENT Act H.R.4895, Lowering Drug Costs for American Families Act Discussions in support of H.R.2880, Protecting Patients Against PBM Abuses Act H.R.2408, Access to Innovative Treatments Act of 2023
CPT - Copyright/Patent/Trademark TAX - Taxation/Internal Revenue Code MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 2 - HOUSE OF REPRESENTATIVES 2 - HOUSE OF REPRESENTATIVES 136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BRISTOL-MYERS SQUIBB COMPANY
801 Pennsylvania Ave, NW, Suite 745, WASHINGTON, DC, 20004, US
LANE PENRY JOHN DEOUDES LANE PENRY PAUL ANTHONY WILLIAMS CAROLINE TUCKER JOHN DEOUDES STEPHANIE A. DYSON THOMAS BRUNET KATHRYN NOVARIA LANE PENRY PAUL ANTHONY WILLIAMS